The Procter & Gamble Company acquires Thorne from L Catterton
The $3.8 billion cash transaction follows L Catterton's three-year investment that grew the 40-year-old provider's business through digital and AI capabilities.
Takeaways
- Thorne is a leader in science-backed health and wellness solutions.
- L Catterton is selling Thorne to Procter & Gamble.
- The business serves health and wellness.
The Procter & Gamble Company has agreed to acquire Thorne, a 40-year-old developer of science-backed vitamins and supplements, from L Catterton for $3.8 billion in cash.
Thorne sells to healthcare practitioners and consumers and has built a proprietary AI wellness advisor to educate consumers.
L Catterton invested in Thorne in October 2023 and grew the business through leadership additions, digital and AI capabilities, and manufacturing upgrades.
The transaction is expected to close in the fourth quarter of 2026.
Get tomorrow morning's tape in your inbox.
Yesterday's platforms, add-ons, recaps, and exits, cleaned up before the workday starts.